Purpose
The purpose of this study was to evaluate the ability of poly(ethylene glycol)-coated lipid nanocapsules (LN) to deliver the highly potent hydrophobic anticancer drug docetaxel to solid tumors.
Methods
Docetaxel-loaded nanocapsules (80–120 nm) were produced by a solvent-free phase inversion process and were coated with polyethylene glycol distearoylphosphatidylethanolamine conjugate by a postinsertion step. In vivo studies were conducted in mice bearing subcutaneously implanted C26 colon adenocarcinoma to assess the pharmacokinetics and biodistribution of both the drug and LN.
Results
Incorporation of docetaxel into the LN dramatically increased the drug's biological half-life while providing substantial accumulation at the tumoral site. The pharmacokinetics and biodistribution pattern were found to depend on the specific surface area and shell composition of the nanocapsules.
Conclusion
This study demonstrates that docetaxel physically entrapped into a lipid colloidal drug carrier can be efficiently targeted to neoplastic tissues.
Similar content being viewed by others
References
D. C. Drummond O. Meyer K. Hong D. B. Kirpotin D. Papahadjopoulos (1999) ArticleTitleOptimizing liposomes for delivery of chemotherapeutic agents to solid tumors Pharmacol. Rev. 51 691–743 Occurrence Handle1:CAS:528:DC%2BD3cXnslChsLg%3D Occurrence Handle10581328
I. Brigger C. Dubernet P. Couvreur (2002) ArticleTitleNanoparticles in cancer therapy and diagnosis Adv. Drug Deliv. Rev. 54 631–651 Occurrence Handle10.1016/S0169-409X(02)00044-3 Occurrence Handle1:CAS:528:DC%2BD38XmsVeqtrs%3D Occurrence Handle12204596
M. C. Jones J. C. Leroux (1999) ArticleTitlePolymeric micelles—a new generation of colloidal drug carriers Eur. J. Pharm. Biopharm. 48 101–111 Occurrence Handle10.1016/S0939-6411(99)00039-9 Occurrence Handle1:CAS:528:DyaK1MXmtVymurk%3D Occurrence Handle10469928
S. M. Moghimi A. C. Hunt J. C. Murray (2001) ArticleTitleLong-circulating and target-specific nanoparticles: theory to practice Pharmacol. Rev. 53 283–318 Occurrence Handle1:CAS:528:DC%2BD3MXkt1Gnurc%3D Occurrence Handle11356986
D. Papahadjopoulos T. M. Allen A. Gabizon E. Mayhew K. Matthay S. K. Huang K. D. Lee M. C. Woodle D. D. Lasic C. Redemann F. J. Martin (1991) ArticleTitleSterically stabilized liposomes: improvement in pharmacokinetics and antitumor therapeutic efficacy Proc. Natl. Acad. Sci. U.S.A. 88 11460–11464 Occurrence Handle1:CAS:528:DyaK38XmslWjsg%3D%3D Occurrence Handle1763060
M. S. Webb D. Saxon F. M. P. Wong H. J. Lim Z. Wang M. B. Bally L. S. L. Choi P. R. Cullis L. D. Mayer (1998) ArticleTitleComparison of different hydrophobic anchors conjugated to poly(ethylene glycol): effects on the pharmacokinetics of liposomal vincristine Biochim. Biophys. Acta 1372 272–282 Occurrence Handle1:CAS:528:DyaK1cXks1Krsr8%3D Occurrence Handle9675310
R. Gref Y. Minamitake M. T. Peracchia V. S. Trubetskoy V. Torchilin R. Langer (1994) ArticleTitleBiodegradable long circulating polymeric nanospheres Science 263 1600–1603 Occurrence Handle1:CAS:528:DyaK2cXit1KktLc%3D Occurrence Handle8128245
R. Duncan S. Gac-Breton R. Keane R. Musila Y. N. Sat R. Satchi F. Searle (2001) ArticleTitlePolymer–drug conjugates, PDEPT and PELT: basic principles for design and transfer from the laboratory to the clinic J. Control. Release 74 135–146 Occurrence Handle10.1016/S0168-3659(01)00328-5 Occurrence Handle1:CAS:528:DC%2BD3MXlslans74%3D Occurrence Handle11489490
F. Yuan M. Leunig S. K. Huang D. A. Berk D. Papahadjopoulos R. K. Jain (1994) ArticleTitleMicrovascular permeability and interstitial penetration of sterically stabilized (Stealth) liposomes in a human tumor xenograft Cancer Res. 54 3352–3356 Occurrence Handle1:CAS:528:DyaK2cXltFOmsr8%3D Occurrence Handle8012948
R. K. Jain (1997) ArticleTitleDelivery of molecular and cellular medicine to solid tumors Adv. Drug Deliv. Rev. 26 71–90 Occurrence Handle10.1016/S0169-409X(97)00027-6 Occurrence Handle1:CAS:528:DyaK2sXktlCrsLw%3D Occurrence Handle10837535
N. Z. Wu D. Da T. L. Rudoll D. Needham A. R. Whorton M. W. Dewhirst (1993) ArticleTitleIncreased microvascular permeability contributes to preferential accumulation of stealth liposomes in tumor tissue Cancer Res. 53 3765–3770 Occurrence Handle1:CAS:528:DyaK3sXmtlertLw%3D Occurrence Handle8339289
S. C. Kim D. W. Kim Y. H. Shim J. S. Bang H. S. Oh S. W. Kim M. H. Seo (2001) ArticleTitleIn vivo evaluation of polymeric micellar paclitaxel formulation: toxicity and efficacy J. Control. Release 72 191–202 Occurrence Handle10.1016/S0168-3659(01)00275-9 Occurrence Handle1:CAS:528:DC%2BD3MXktVGks7s%3D Occurrence Handle11389998
D. Garrec ParticleLe S. Gori L. Luo D. Lessard D. C. Smith M. A. Yessine M. Ranger J. C. Leroux (2004) ArticleTitlePoly(N-vinylpyrrolidone)-block-poly(d,l-lactide) as a new polymeric solubilizer for hydrophobic anticancer drugs: in vitro and in vivo evaluation J. Control. Release 99 83–101 Occurrence Handle10.1016/j.jconrel.2004.06.018 Occurrence Handle15342183
T. Y. Kim D. W. Kim J. Y. Chung S. G. Shin S. C. Kim D. S. Heo N. K. Kim Y. J. Bang (2004) ArticleTitlePhase I and pharmacokinetic stidy of Genexol-PM, a Cremophor free, polymeric micelle-formulated paclitaxel, in patients with advanced malignancies Clin. Cancer Res. 10 3708–3716 Occurrence Handle10.1158/1078-0432.CCR-03-0655 Occurrence Handle1:CAS:528:DC%2BD2cXksVKntr4%3D Occurrence Handle15173077
A. Sharma E. Mayhew L. Bolcsak C. Cavanaugh P. Harmon A. S. Janoff J. Bernacki (1997) ArticleTitleActivity of paclitaxel liposome formulations against human ovarian tumor xenograft Int. J. Cancer 71 103–107 Occurrence Handle10.1002/(SICI)1097-0215(19970328)71:1<103::AID-IJC17>3.0.CO;2-J Occurrence Handle1:CAS:528:DyaK2sXis1Kisrw%3D Occurrence Handle9096672
P. P. Constantinides A. Tustian D. R. Kessler (2004) ArticleTitleTocol emulsions for drug solubilization and parenteral delivery Adv. Drug Deliv. Rev. 56 1243–1255 Occurrence Handle10.1016/j.addr.2003.12.005 Occurrence Handle1:CAS:528:DC%2BD2cXjtl2ktrs%3D Occurrence Handle15109767
B. T. Hill R. D. H. Whelan S. A. Shellard S. McClean L. K. Hosking (1994) ArticleTitleDifferential cytotoxic effects of docetaxel in a range of mammalian tumor cell lines and certain drug resistant sublines in vitro Invest. New Drugs 12 169–182 Occurrence Handle10.1007/BF00873957 Occurrence Handle1:CAS:528:DyaK2MXjsVCmtb4%3D Occurrence Handle7896535
M. C. Bissery D. Guénard F. Guéritte-Voegelein F. Lavelle (1991) ArticleTitleExperimental antitumor activity of Taxotere (RP 56976, NSC 628503), a Taxol analogue Cancer Res. 5 4845–4852
A. J. Tije ParticleTen J. Verweij W. J. Loos A. Sparreboom (2003) ArticleTitlePharmacological effects of formulation vehicles—implications for cancer chemotherapy Clin. Pharmacokinet. 42 665–685 Occurrence Handle10.2165/00003088-200342070-00005 Occurrence Handle12844327
D. Garrec ParticleLe M. Ranger J. C. Leroux (2004) ArticleTitleMicelles in anticancer drug delivery Am. J. Drug Deliv. 2 15–42 Occurrence Handle10.2165/00137696-200402010-00002
J. Szebeni (2001) ArticleTitleComplement activation-related pseudoallergy caused by liposomes, micellar carriers of intravenous drugs and radiocontrast agents Crit. Rev. Ther. Drug Carrier Syst. 18 567–606 Occurrence Handle1:CAS:528:DC%2BD38XlvFCrtg%3D%3D Occurrence Handle11789676
N. Kang M. E. Perron R. E. Prud'Homme Y. Zhang G. Gaucher J. C. Leroux (2005) ArticleTitleStereocomplex block copolymer micelles: core–shell structures with enhanced stability Nano Lett. 5 315–319 Occurrence Handle10.1021/nl048037v Occurrence Handle1:CAS:528:DC%2BD2MXkvFWisQ%3D%3D Occurrence Handle15794618
X. Zhang H. M. Burt G. Mangold D. Dexter D. Hoff ParticleVon L. Mayer W. L. Hunter (1997) ArticleTitleAnti-tumor efficacy and biodistribution of intravenous polymeric micellar paclitaxel Anti-Cancer Drugs 8 686–701
X. Shuai T. Merdan A. K. Schaper F. Xi T. Kissel (2004) ArticleTitleCore-cross-linked polymeric micelles as paclitaxel carriers Bioconjug. Chem. 15 441–448 Occurrence Handle10.1021/bc034113u Occurrence Handle1:CAS:528:DC%2BD2cXjsFGgsrk%3D Occurrence Handle15149170
J. L. Liu C. Allen (2004) ArticleTitlePolymer–drug compatibility: a guide to the development of delivery systems for the anticancer agent, ellipticine J. Pharm. Sci. 93 132–143 Occurrence Handle10.1002/jps.10533 Occurrence Handle1:CAS:528:DC%2BD2cXjvFWnsw%3D%3D Occurrence Handle14648643
T. Hamaguchi Y. Matsumara M. Suzuki K. Shimizu R. Goda I. Nakamura I. Nakatomi M. Yokoyama K. Kataoka T. Kakizoe (2005) ArticleTitleNK105, a paclitaxel-incorporating micellar nanoparticle formulation can extend in vivo antitumor activity and reduce the neurotoxicity of paclitaxel Br. J. Cancer 92 1240–1246 Occurrence Handle10.1038/sj.bjc.6602479 Occurrence Handle1:CAS:528:DC%2BD2MXivFWlt7k%3D Occurrence Handle15785749
N. K. Ibrahim N. Desai S. Legha P. Soon-Shiong R. L. Theriault E. Rivera B. Esmaeli S. E. Ring A. Bedikian G. N. Hortobayi J. A. Ellerhost (2002) ArticleTitlePhase I and pharmacokinetic study of ABI-007, a cremophor-free protein stabilized, nanoparticle formulation of paclitaxel Clin. Cancer Res. 8 1038–1044 Occurrence Handle1:CAS:528:DC%2BD38XksVSqurg%3D Occurrence Handle12006516
J. W. Singer B. Baker P. Vries ParticleDe A. Kumar S. Shaffer E. Vawter M. Bolton P. Garzone (2003) Poly-(l)-glutamic acid-paclitaxel (CT-2103) [XYOTAX], a biodegradable polymeric drug conjugate: characterization, preclinical pharmacology, and preliminary clinical data H. Maeda A. Kabanov K. Kataoka T. Okano (Eds) Polymer Drugs in the Clinical Stage Kluwer Academic/Plenum Publishers New York 81–99
D. Hoarau P. Delmas S. David E. Roux J. C. Leroux (2004) ArticleTitleNovel long-circulating lipid nanocapsules Pharm. Res. 21 1783–1789 Occurrence Handle10.1023/B:PHAM.0000045229.87844.21 Occurrence Handle1:CAS:528:DC%2BD2cXos1WqtL0%3D Occurrence Handle15553223
B. Heurtault P. Saulnier B. Pech J. E. Proust J. P. Benoit (2002) ArticleTitleA novel phase inversion-based process for the preparation of lipid nanocarriers Pharm. Res. 19 875–880 Occurrence Handle10.1023/A:1016121319668 Occurrence Handle1:CAS:528:DC%2BD38XltVSgtrs%3D Occurrence Handle12134960
P. S. Uster T. M. Allen B. E. Daniel C. J. Mendez M. S. Newman G. Z. Zhu (1996) ArticleTitleInsertion of poly(ethylene glycol) derivatized phospholipid into pre-formed liposomes results in prolonged in vivo circulation time FEBS Lett. 386 243–246 Occurrence Handle10.1016/0014-5793(96)00452-8 Occurrence Handle1:CAS:528:DyaK28Xjs1Wntro%3D Occurrence Handle8647291
M. Ramaswamy X. Zhang H. M. Burt K. M. Wasan (1997) ArticleTitleHuman plasma distribution of free paclitaxel and paclitaxel associated with diblock copolymers J. Pharm. Sci. 86 460–464 Occurrence Handle10.1021/js960333n Occurrence Handle1:CAS:528:DyaK2sXhslamt7k%3D Occurrence Handle9109049
J. A. MacKay D. F. Deen F. C. Szoka SuffixJr (2005) ArticleTitleDistribution in brain of liposomes after convection enhanced delivery; modulation by particle charge, particle diameter, and presence of steric coating Brain Res. 1035 139–153 Occurrence Handle10.1016/j.brainres.2004.12.007 Occurrence Handle1:CAS:528:DC%2BD2MXhslWktLs%3D Occurrence Handle15722054
T. L. Andresen S. S. Jensen K. Jorgensen (2005) ArticleTitleAdvanced strategies in liposomal cancer therapy: problems and prospects of active and tumor specific disease Prog. Lipid Res. 44 68–97 Occurrence Handle10.1016/j.plipres.2004.12.001 Occurrence Handle1:CAS:528:DC%2BD2MXhvVCjtb8%3D Occurrence Handle15748655
V. S. Trubetskoy V. P. Torchilin (1995) ArticleTitleUse of polyethylene–lipid conjugates as long-circulating carriers for delivery of therapeutic and diagnostic agents Adv. Drug Deliv. Rev. 16 311–320 Occurrence Handle10.1016/0169-409X(95)00032-3 Occurrence Handle1:CAS:528:DyaK2MXpt1amt7o%3D
Acknowledgment
The Canada Research Chair program is acknowledged for financial support.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Khalid, M.N., Simard, P., Hoarau, D. et al. Long Circulating Poly(Ethylene Glycol)-Decorated Lipid Nanocapsules Deliver Docetaxel to Solid Tumors. Pharm Res 23, 752–758 (2006). https://doi.org/10.1007/s11095-006-9662-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11095-006-9662-5